Cargando…
Impact of early anti-TNF use on clinical outcomes in Crohn’s disease: a nationwide population-based study
BACKGROUND/AIMS: The optimal timing for initiation of anti-tumor necrosis factor (TNF) therapy in Crohn’s disease (CD) is still debated. Little is known about the clinical outcomes of early versus late administration of anti-TNF agents, especially in Asian CD patients. We aimed to evaluate the impac...
Autores principales: | Jung, Yoon Suk, Han, Minkyung, Park, Sohee, Cheon, Jae Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487310/ https://www.ncbi.nlm.nih.gov/pubmed/32306709 http://dx.doi.org/10.3904/kjim.2020.001 |
Ejemplares similares
-
Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study
por: Han, Minkyung, et al.
Publicado: (2020) -
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
por: Jung, Yoon Suk, et al.
Publicado: (2021) -
Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
por: Han, Minkyung, et al.
Publicado: (2018) -
Cancer risk in Korean patients with Behçet’s disease: A nationwide population-based study
por: Jung, Yoon Suk, et al.
Publicado: (2017) -
Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
por: Han, Minkyung, et al.
Publicado: (2020)